The Netherlands Heart Tissue Bank

Autor: M. T. H. M. Henkens, J. F. van Ast, A. S. J. M. te Riele, A. C. Houweling, A. S. Amin, R. Nijveldt, M. L. Antoni, X. Li, S. M. T. Wehrens, J. H. von der Thüsen, K. Damman, E. N. ter Horst, O. C. Manintveld, R. Y. Abma-Schouten, H. W. M. Niessen, H. H. W. Silljé, J. W. Jukema, P. A. Doevendans

Publikováno v: Netherlands Heart Journal, 31(1), 16-20. Bohn Stafleu van Loghum
Netherlands heart journal, 31(1), 16-20. Bohn Stafleu van Loghum
Netherlands Heart Journal, 31, 1, pp. 16-20
Netherlands Heart Journal, 31, 16-20. Bohn Stafleu van Loghum
Netherlands Heart Journal, 31, 16-20
Henkens, M T H M, van Ast, J F, te Riele, A S J M, Houweling, A C, Amin, A S, Nijveldt, R, Antoni, M L, Li, X, Wehrens, S M T, von der Thüsen, J H, Damman, K, ter Horst, E N, Manintveld, O C, Abma-Schouten, R Y, Niessen, H W M, Silljé, H H W, Jukema, J W & Doevendans, P A 2023, ' The Netherlands Heart Tissue Bank : Strengthening the cardiovascular research infrastructure with an open access Cardiac Tissue Repository ', Netherlands Heart Journal, vol. 31, no. 1, pp. 16-20 . https://doi.org/10.1007/s12471-022-01713-8

Aim Cardiac diseases remain a leading cause of cardiovascular disease (CVD) related hospitalisation and mortality. That is why research to improve our understanding of pathophysiological processes underlying cardiac diseases is of great importance. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2662fc11a44ad1a8c0a23dfe9ebfd774
https://doi.org/10.1007/s12471-022-01713-8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure

Autor: I. E. Beldhuis, J. M. ter Maaten, S. M. Figarska, K. Damman, P. S. Pang, B. Greenberg, B. A. Davison, G. Cotter, T. Severin, C. Gimpelewicz, G. M. Felker, G. Filippatos, J. R. Teerlink, M. Metra, A. A. Voors

Publikováno v: Clinical Research in Cardiology.

Background We aimed to study whether improvement in renal function by serelaxin in patients who were hospitalized for acute heart failure (HF) might explain any potential effect on clinical outcomes. Methods We included 6318 patients from the RELAXin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::db47d5a734efa2dca174fb593b692e5e
https://doi.org/10.1007/s00392-022-02144-6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.